On the optimal sodium correction rate in hyponatraemia and clinical outcome: a meta-analysis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating Sodium Correction Rates in Hyponatraemia: A Meta-Analysis on Clinical Outcomes

  • By

  • Ludwig Matrisch

  • Yannick Rau

  • Lars Graßhoff

  • Martin Nitschke

  • October 1, 2026

Share

Clinical Report: Evaluating Sodium Correction Rates in Hyponatraemia

Overview

This meta-analysis indicates that slow serum sodium correction in hyponatraemia is associated with increased mortality.

Background

Hyponatraemia is a prevalent electrolyte disorder that significantly impacts morbidity and mortality among hospitalized patients. Current guidelines advocate for slow correction of sodium levels to mitigate the risk of osmotic demyelination syndrome (ODS). The relationship between correction rates and mortality is under investigation.

Data Highlights

No specific numerical data or trial results were provided in the source material.

Key Findings

  • Slow serum sodium correction is linked to higher mortality rates in hyponatraemia.
  • Current guidelines recommend a correction rate of 4–8 mmol/L, with a maximum of 10–12 mmol/L in the first 24 hours.
  • Osmotic demyelination syndrome (ODS) is a serious risk associated with rapid correction.
  • The study synthesized evidence from various articles to evaluate the impact of correction rates on mortality.

Clinical Implications

Clinicians should be aware of the risks associated with sodium correction in hyponatraemia.

Conclusion

The findings from this meta-analysis provide insights into sodium correction rates in hyponatraemia.

Related Resources & Content

  1. Conexiant, Source, 2026 -- Faster Sodium Correction Gains Support
  2. The Journal of Clinical Endocrinology & Metabolism, Source, 2026 -- Evaluating Copeptin's Significance in Emergency Department Admissions for Patients with Hypotonic Hyponatremia
  3. Outcomes and Management Strategies for Postoperative Hyponatraemia After Transsphenoidal Surgery: A Retrospective Observational Analysis
  4. Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia, JAMA Internal Medicine, 2025
  5. The Journal of Clinical Endocrinology & Metabolism — Comparison of Tolvaptan and Fluid Restriction for Managing Moderate to Severe Hyponatremia: Results from a Randomized Open-Label Trial
  6. Hyponatremia - StatPearls - NCBI Bookshelf
  7. Hyponatremia - Symptoms, diagnosis and treatment | BMJ Best Practice US
  8. (PDF) On the optimal sodium correction rate in hyponatraemia and clinical outcome: a meta-analysis
  9. Correction Rates and Clinical Outcomes in Hospitalized Adults With Severe Hyponatremia
  10. Correction Rate Matters in Severe Hyponatremia | JAMA Internal Medicine | JAMA Network
  11. Hyponatremia Correction and Osmotic Demyelination Syndrome Risk: A Systematic Review and Meta-Analysis - PMC
  12. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial - PMC
  13. Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic

Original Source(s)

On the optimal sodium correction rate in hyponatraemia and clinical outcome: a meta-analysis

  • by Ludwig Matrisch, Yannick Rau, Lars Graßhoff, Martin Nitschke

  • October 1, 2026

Related Content

VA/DoD guideline broadens tobacco treatment

Recommendations prioritize varenicline and combination NRT while extending pharmacotherapy to patients not ready to quit.

Female patients less likely to receive invasive care

Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.

Lasers trigger pigmentation from past gold therapy

Short-pulse lasers triggered chrysiasis more than 30 years after treatment in 2 patients with rheumatoid arthritis.